Get started
Health Catalyst, IncHealth Catalyst, IncHealth Catalyst, Inc

Health Catalyst, Inc

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

HCAT chart


Full chart

HCAT upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪501.38 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.35 USD
Net income (FY)
‪−118.15 M‬ USD
Revenue (FY)
‪295.94 M‬ USD
Shares float
‪58.32 M‬
Beta (1Y)
1.57

Employees


Employees (FY)
‪1.3 K‬
Change (1Y)
+100 +8.33%
Revenue / Employee (1Y)
‪227.64 K‬ USD
Net income / Employee (1Y)
‪−90.88 K‬ USD

About Health Catalyst, Inc


Sector
Technology Services
Industry
Packaged Software
CEO
Daniel D. Burton
Website
healthcatalyst.com
Headquarters
South Jordan
Founded
2008
FIGI
BBG00LDPZMS6
Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in South Jordan, UT.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

HCAT news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

HCAT highest yielding bonds


HCAT5169905
Health Catalyst, Inc. 2.5% 15-APR-2025
Yield to maturity
4.03%
Maturity date
Apr 15, 2025

Explore more bonds 

Frequently Asked Questions


The current price of HCAT is 8.24 USD — it has decreased by −7.00% in the past 24 hours. Watch Health Catalyst, Inc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Health Catalyst, Inc stocks are traded under the ticker HCAT.
HCAT stock has risen by 4.97% compared to the previous week, the month change is a 5.51% rise, over the last year Health Catalyst, Inc has showed a 11.65% increase.
We've gathered analysts' opinions on Health Catalyst, Inc future price: according to them, HCAT price has a max estimate of 16.00 USD and a min estimate of 7.00 USD. Watch HCAT chart and read a more detailed Health Catalyst, Inc stock forecast: see what analysts think of Health Catalyst, Inc and suggest that you do with its stocks.
HCAT reached its all-time high on Aug 6, 2021 with the price of 59.50 USD, and its all-time low was 5.42 USD and was reached on Aug 7, 2024. View more price dynamics on HCAT chart.
See other stocks reaching their highest and lowest prices.
HCAT stock is 9.60% volatile and has beta coefficient of 1.57. Track Health Catalyst, Inc stock price on the chart and check out the list of the most volatile stocks — is Health Catalyst, Inc there?
Today Health Catalyst, Inc has the market capitalization of ‪501.38 M‬, it has increased by 3.34% over the last week.
Yes, you can track Health Catalyst, Inc financials in yearly and quarterly reports right on TradingView.
Health Catalyst, Inc is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
HCAT earnings for the last quarter are 0.07 USD per share, whereas the estimation was 0.10 USD resulting in a −27.38% surprise. The estimated earnings for the next quarter are 0.08 USD per share. See more details about Health Catalyst, Inc earnings.
Health Catalyst, Inc revenue for the last quarter amounts to ‪76.35 M‬ USD, despite the estimated figure of ‪76.27 M‬ USD. In the next quarter, revenue is expected to reach ‪80.62 M‬ USD.
HCAT net income for the last quarter is ‪−14.73 M‬ USD, while the quarter before that showed ‪−13.52 M‬ USD of net income which accounts for −8.95% change. Track more Health Catalyst, Inc financial stats to get the full picture.
No, HCAT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 9, 2024, the company has ‪1.30 K‬ employees. See our rating of the largest employees — is Health Catalyst, Inc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Health Catalyst, Inc EBITDA is ‪−20.08 M‬ USD, and current EBITDA margin is −13.70%. See more stats in Health Catalyst, Inc financial statements.
Like other stocks, HCAT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Health Catalyst, Inc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Health Catalyst, Inc technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Health Catalyst, Inc stock shows the sell signal. See more of Health Catalyst, Inc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.